13F filer · CIK 1418329 ↗

Ninety One UK Ltd

You are looking at Q4 2025. See the latest, Q3 2026 →

Reported value

$46.64B

−49% on the quarter before

Positions

225

23 new · 8 sold out

Top 10

38.2%

of the value

Est. gain

+$1.09B

on stocks held all quarter

Est. return

+2.4%

on those stocks since Q3 2025

Filed

Jan 27, 2026

On SEC EDGAR ↗

Positions as of Dec 31, 2025, from Ninety One UK Ltd's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

New
Added
Cut
Same
Options

The 24 largest positions, 60% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2025. Striped tiles are options.

Microsoft6.8%Alphabet6.0%Nvidia5.0%Visa Inc.4.6%

Johnson & Johnson3.0%

Autodesk2.9%Broadcom2.7%

Philip Morris International Inc2.5%

Booking Holdings Inc2.4%

Tko Group Holdings Inc2.2%

Amazon2.2%Intuit2.0%

Netease Inc1.9%

Electronic Arts Inc1.8%

Apple1.7%Mastercard1.5%

Edwards Lifesciences Corp1.4%

Monster Beverage Corp1.4%

Marsh & Mclennan Cos Inc1.4%

Jpmorgan Chase & Co1.4%

TSMC1.3%Automatic Data Processing1.3%

Barrick Mining Corp1.2%

Eli Lilly1.2%

Microsoft6.8%Alphabet6.0%Nvidia5.0%Visa Inc.4.6%

Johnson & Johnson3.0%

Autodesk2.9%Broadcom2.7%

Philip Morris International Inc2.5%

Booking Holdings Inc2.4%

Tko Group Holdings Inc2.2%

Amazon2.2%Intuit2.0%

Netease Inc1.9%

Electronic Arts Inc1.8%

Apple1.7%Mastercard1.5%

Edwards Lifesciences Corp1.4%

Monster Beverage Corp1.4%

Marsh & Mclennan Cos Inc1.4%

Jpmorgan Chase & Co1.4%

TSMC1.3%Automatic Data Processing1.3%

Barrick Mining Corp1.2%

Eli Lilly1.2%

Largest buys

Since Q3 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

Abbott Laboratories~$336.8MNew · 0.0% → 0.7%+2,688,282 shares
Marsh & Mclennan Cos Inc~$157.4MAdded · 0.6% → 1.4%+848,398 shares
Meta~$153.0MAdded · 0.1% → 0.6%+231,763 shares
Trimble~$67.7MNew · 0.0% → 0.1%+864,598 shares
Valmont Industries Inc~$66.1MNew · 0.0% → 0.1%+164,305 shares
Colgate-Palmolive Co~$60.4MNew · 0.0% → 0.1%+764,928 shares
Totalenergies Se~$59.7MNew · 0.0% → 0.1%+915,180 shares
General Electric Co~$21.2MNew · 0.0% → 0.0%+68,982 shares
Copart Inc~$19.6MNew · 0.0% → 0.0%+500,510 shares
Centene Corp~$16.9MAdded · 0.1% → 0.2%+410,024 shares

Largest sells

Since Q3 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

Microsoft~$4.02BCut · 8.4% → 6.8%−8,314,001 shares
Alphabet~$2.76BCut · 4.7% → 6.0%−8,826,445 shares
Visa Inc.~$2.24BCut · 4.7% → 4.6%−6,389,644 shares
Nvidia~$2.03BCut · 4.8% → 5.0%−10,871,648 shares
Autodesk~$1.55BCut · 3.4% → 2.9%−5,250,517 shares
Broadcom~$1.36BCut · 2.7% → 2.7%−3,925,688 shares
Johnson & Johnson~$1.34BCut · 2.7% → 3.0%−6,469,484 shares
Amazon~$1.33BCut · 2.4% → 2.2%−5,752,026 shares
Booking Holdings Inc~$1.18BCut · 2.5% → 2.4%−220,555 shares
Philip Morris International Inc~$1.16BCut · 2.5% → 2.5%−7,233,339 shares

Holdings

As of Dec 31, 2025. Changes are in shares against Sep 30, 2025, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
#	Holding		% prev	Value	Shares		Price	Prev price
1	MicrosoftCommon Stock · shares −56% · price −6.6%	6.8%	8.4%	$3.19B	6.6M	−56%	$483.62	$517.95	−6.6%	−$226.3M
2	AlphabetCommon Stock · shares −50% · price +28.8%	6.0%	4.7%	$2.81B	9.0M	−50%	$313.00	$243.10	+28.8%	+$627.7M
3	NvidiaCommon Stock · shares −46% · price −0.0%	5.0%	4.8%	$2.33B	12.5M	−46%	$186.50	$186.58	−0.0%	−$1.0M
4	Visa Inc.Common Stock · shares −51% · price +2.7%	4.6%	4.7%	$2.14B	6.1M	−51%	$350.71	$341.38	+2.7%	+$57.1M
5	Johnson & JohnsonCommon Stock · shares −49% · price +11.6%	3.0%	2.7%	$1.41B	6.8M	−49%	$206.95	$185.42	+11.6%	+$146.6M
6	AutodeskCommon Stock · shares −53% · price −6.8%	2.9%	3.4%	$1.37B	4.6M	−53%	$296.01	$317.67	−6.8%	−$100.5M
7	BroadcomCommon Stock · shares −52% · price +4.9%	2.7%	2.7%	$1.24B	3.6M	−52%	$346.10	$329.91	+4.9%	+$58.1M
8	Philip Morris International IncCommon Stock · shares −50% · price −1.1%	2.5%	2.5%	$1.15B	7.2M	−50%	$160.40	$162.20	−1.1%	−$12.9M
9	Booking Holdings IncCommon Stock · shares −51% · price −0.8%	2.4%	2.5%	$1.12B	208,465	−51%	$5,355.33	$5,399.27	−0.8%	−$9.2M
10	Tko Group Holdings IncCommon Stock · shares −50% · price +3.5%	2.2%	2.2%	$1.05B	5.0M	−50%	$209.00	$201.96	+3.5%	+$35.2M
11	AmazonCommon Stock · shares −56% · price +5.1%	2.2%	2.4%	$1.02B	4.4M	−56%	$230.82	$219.57	+5.1%	+$49.9M
12	IntuitCommon Stock · shares −51% · price −3.0%	2.0%	2.1%	$922.3M	1.4M	−51%	$662.42	$682.91	−3.0%	−$28.5M
13	Netease IncADR · shares −50% · price −9.5%	1.9%	2.1%	$866.4M	6.3M	−50%	$137.62	$151.99	−9.5%	−$90.5M
14	Electronic Arts IncCommon Stock · shares −51% · price +1.3%	1.8%	1.9%	$849.3M	4.2M	−51%	$204.33	$201.70	+1.3%	+$10.9M
15	AppleCommon Stock · shares −47% · price +6.8%	1.7%	1.6%	$814.1M	3.0M	−47%	$271.86	$254.63	+6.8%	+$51.6M
16	MastercardCommon Stock · shares −49% · price +0.4%	1.5%	1.5%	$706.0M	1.2M	−49%	$570.88	$568.81	+0.4%	+$2.6M
17	Edwards Lifesciences CorpCommon Stock · shares −51% · price +9.6%	1.4%	1.3%	$659.4M	7.7M	−51%	$85.25	$77.77	+9.6%	+$57.9M
18	Monster Beverage CorpCommon Stock · shares −57% · price +13.9%	1.4%	1.5%	$658.3M	8.6M	−57%	$76.67	$67.31	+13.9%	+$80.4M
19	Marsh & Mclennan Cos IncCommon Stock · shares +31% · price −7.9%	1.4%	0.59%	$657.1M	3.5M	+31%	$185.52	$201.53	−7.9%	−$43.1M
20	Jpmorgan Chase & CoCommon Stock · shares −57% · price +2.2%	1.4%	1.6%	$651.4M	2.0M	−57%	$322.22	$315.43	+2.2%	+$13.7M
21	TSMCADR · shares −52% · price +8.8%	1.3%	1.3%	$611.7M	2.0M	−52%	$303.89	$279.29	+8.8%	+$49.5M
22	Automatic Data ProcessingCommon Stock · shares −51% · price −12.4%	1.3%	1.5%	$610.9M	2.4M	−51%	$257.23	$293.50	−12.4%	−$86.1M
23	Barrick Mining CorpCommon Stock · shares −52% · price +32.9%	1.2%	0.99%	$581.5M	13.4M	−52%	$43.55	$32.77	+32.9%	+$143.9M
24	Eli LillyCommon Stock · shares −38% · price +40.8%	1.2%	0.73%	$581.4M	541,004	−38%	$1,074.68	$763.00	+40.8%	+$168.6M
25	Icon PlcCommon Stock · shares −51% · price +4.1%	1.2%	1.1%	$536.8M	2.9M	−51%	$182.22	$175.00	+4.1%	+$21.3M
	Total · 225 positions	100%		$46.64B						+$1.09B

The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2025 to Q4 2025: 202 stocks held throughout, up $1.09B (+2.4%).

Alphabet+$627.7M+29%
Eli Lilly+$168.6M+41%
Johnson & Johnson+$146.6M+12%
Barrick Mining Corp+$143.9M+33%
General Motors Co+$100.6M+33%
Netease Inc−$90.5M−9%
Ferrari Nv−$99.0M−23%
Motorola Solutions Inc−$99.0M−16%
Autodesk−$100.5M−7%
Microsoft−$226.3M−7%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$100.00B$50.00B$0

Q1 201643 quartersQ3 2026

Every quarter's filing

Each quarter's 13F filing, newest first
Quarter	Filed	Reported value	Positions	Filing
Q3 2026	Oct 15, 2026	$45.47B+2%	331	SEC ↗
Q2 2026	Jul 16, 2026	$44.73B+4%	271	SEC ↗
Q1 2026	Apr 24, 2026	$43.13B−8%	237	SEC ↗
Q4 2025	Jan 27, 2026	$46.64B−49%	225	SEC ↗
Q3 2025	Oct 21, 2025 (amended)	$91.76B+115%	210	SEC ↗
Q2 2025	Jul 18, 2025	$42.61B+19%	202	SEC ↗
Q1 2025	Apr 30, 2025	$35.94B−4%	193	SEC ↗
Q4 2024	Jan 27, 2025	$37.38B−0%	191	SEC ↗
Q3 2024	Nov 12, 2024	$37.47B+3%	194	SEC ↗
Q2 2024	Jul 22, 2024	$36.22B+2%	187	SEC ↗
Q1 2024	Apr 25, 2024	$35.61B+6%	185	SEC ↗
Q4 2023	Jan 31, 2024	$33.61B+6%	178	SEC ↗
Q3 2023	Oct 10, 2023	$31.62B−8%	177	SEC ↗
Q2 2023	Jul 19, 2023	$34.27B+7%	183	SEC ↗
Q1 2023	Apr 28, 2023	$32.10B+3%	180	SEC ↗
Q4 2022	Feb 7, 2023	$31.19B+3%	187	SEC ↗
Q3 2022	Nov 14, 2022	$30.32B−10%	190	SEC ↗
Q2 2022	Aug 15, 2022	$33.63B−14%	190	SEC ↗
Q1 2022	May 26, 2022	$39.26B−7%	196	SEC ↗
Q4 2021	Feb 11, 2022	$42.13B+8%	208	SEC ↗
Q3 2021	Nov 2, 2021	$39.16B+1%	208	SEC ↗
Q2 2021	Aug 12, 2021	$38.59B+10%	209	SEC ↗
Q1 2021	May 7, 2021	$35.18B+8%	215	SEC ↗
Q4 2020	Feb 5, 2021	$32.51B+18%	219	SEC ↗
Q3 2020	Nov 12, 2020	$27.65B−2%	223	SEC ↗
Q2 2020	Sep 4, 2020 (amended)	$28.22B+19%	233	SEC ↗
Q1 2020	May 12, 2020	$23.77B−21%	232	SEC ↗
Q4 2019	Feb 7, 2020	$30.15B+17%	238	SEC ↗
Q3 2019	Nov 14, 2019	$25.69B−2%	235	SEC ↗
Q2 2019	Jul 30, 2019	$26.28B+4%	265	SEC ↗
Q1 2019	Apr 24, 2019	$25.24B+9%	271	SEC ↗
Q4 2018	Feb 8, 2019	$23.19B−13%	283	SEC ↗
Q3 2018	Nov 13, 2018	$26.80B+33%	274	SEC ↗
Q2 2018	Aug 10, 2018	$20.13B+8%	259	SEC ↗
Q1 2018	May 14, 2018	$18.67B−23%	238	SEC ↗
Q4 2017	Feb 13, 2018	$24.34B+7%	306	SEC ↗
Q3 2017	Nov 13, 2017	$22.78B+8%	308	SEC ↗
Q2 2017	Aug 11, 2017	$21.00B+4%	311	SEC ↗
Q1 2017	May 12, 2017	$20.25B+6%	308	SEC ↗
Q4 2016	Feb 10, 2017	$19.15B−7%	305	SEC ↗
Q3 2016	Nov 14, 2016	$20.53B+6%	300	SEC ↗
Q2 2016	Aug 12, 2016	$19.33B+5%	291	SEC ↗
Q1 2016	May 12, 2016	$18.49B	303	SEC ↗